Kiora Pharmaceuticals Inc... (KPRX)
3.25
-0.10 (-3.10%)
At close: Feb 28, 2025, 3:59 PM
3.25
0.00%
After-hours: Feb 28, 2025, 04:00 PM EST
Kiora Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | n/a | n/a | n/a | 12.06K | 2.69M | 1.65M | 407.52K | 669.26K | n/a | n/a | n/a | n/a |
| Cost of Revenue | 4.03M | 134.03K | 227.27K | 200.22K | 4.89K | 8.06M | 10.33M | 8.42M | 1.26K | n/a | n/a | n/a |
| Gross Profit | -4.03M | -134.03K | -227.27K | -188.16K | 2.68M | -6.4M | -9.92M | -7.75M | -1.26K | n/a | n/a | n/a |
| Operating Income | -12.59M | -12.31M | -16.94M | -8.19M | -7M | -10.84M | -14.56M | -13.35M | -6.68M | -2.46M | -3.1M | -5.85M |
| Interest Income | 173.99K | 56.89K | 1.14K | 23.34K | 108.07K | 120.36K | 564.00 | 3.68K | 947.00 | 1.1K | 2.19K | 11.13K |
| Pretax Income | -12.42M | -13.7M | -16.7M | -8.08M | -7M | -10.73M | -14.56M | -13.34M | -8.39M | -1.55M | -3.68M | -5.81M |
| Net Income | -12.51M | -13.58M | -16.39M | -8.09M | -7.1M | -10.81M | -13.22M | -13.34M | -8.39M | -1.77M | -3.88M | -6.03M |
| Selling & General & Admin | 4.66M | 8.28M | 5.32M | 4.66M | 4.41M | 4.44M | 4.64M | 5.59M | 3.96M | 1.93M | 2.09M | 2.82M |
| Research & Development | 4.03M | 3.45M | 5.35M | 3.57M | 5.39M | 8.06M | 10.33M | 8.42M | 2.72M | 531.12K | 1.01M | 3.03M |
| Other Expenses | -130.32K | 582.61K | 6.27M | n/a | n/a | n/a | 4.64M | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 8.56M | 11.73M | 10.67M | 8.22M | 9.8M | 12.5M | 14.97M | 14.02M | 6.68M | 2.46M | 3.1M | 5.85M |
| Interest Expense | 11.13K | 8.6K | 6.85K | 4.19K | 325.00 | 1.04K | 1.22K | 275.00 | 1.93M | 441.72K | 611.39K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 12.59M | 11.73M | 10.67M | 8.22M | 9.8M | 12.5M | 14.97M | 14.02M | 6.68M | 2.46M | 3.1M | 5.85M |
| Income Tax | 90.32K | -113.01K | -304.78K | 12.05K | 95.4K | 86.05K | -1.34M | 3.68K | 1.94M | 664.2K | 808.25K | 225.72K |
| Shares Outstanding (Basic) | 538.01K | 732.3K | 241.1K | 114.79K | 79.53K | 59.14K | 23.77K | 14.72K | 10.27K | 11.57K | 8.89K | 8.89K |
| Shares Outstanding (Diluted) | 538.01K | 732.3K | 241.1K | 114.79K | 79.53K | 59.14K | 23.77K | 14.72K | 10.27K | 11.57K | 8.89K | 8.89K |
| EPS (Basic) | -24.25 | -18.55 | -68 | -70.5 | -89.24 | -182.81 | -556.17 | -906.3 | -817.01 | -153.35 | -436.38 | -678.75 |
| EPS (Diluted) | -24.25 | -18.55 | -68 | -70.5 | -89.24 | -182.81 | -556.17 | -906.3 | -817.01 | -153.35 | -436.38 | -678.75 |
| EBITDA | -12.35M | -13.55M | -13.73M | -6.65M | -6.79M | -10.69M | -14.54M | -13.34M | -6.68M | -2.24M | -3.07M | -5.83M |
| Depreciation & Amortization | 62.42K | 134.03K | 227.27K | 200.22K | 213.93K | 38.48K | 19.29K | 5.18K | 1.26K | 1.72K | 5.46K | 9.09K |